Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Diana Crivellari
A Different Immunologic Profile Characterizes Patients With HER-2-overexpressing and HER-2-negative Locally Advanced Breast Cancer: Implications for Immune-Based Therapies
Breast Cancer Research
Cancer Research
Oncology
Related publications
Serum HER-2 Concentration in Patients With Primary Breast Cancer
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
PTEN Expression as a Predictor for the Response to Trastuzumab-Based Therapy in Her-2 Overexpressing Metastatic Breast Cancer
PLoS ONE
Multidisciplinary
Aloe-Emodin Inhibits HER-2 Expression Through the Downregulation of Y-Box Binding Protein-1 in HER-2-overexpressing Human Breast Cancer Cells
Oncotarget
Oncology
Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer
Medical Journal Armed Forces India
Medicine
Chemosensitization of HER-2/neu-overexpressing Human Breast Cancer Cells to Paclitaxel (Taxol) by Adenovirus Type 5 E1A
Oncogene
Cancer Research
Genetics
Molecular Biology
HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Trastuzumab in Combination With Metronomic Cyclophosphamide and Methotrexate in Patients With HER-2 Positive Metastatic Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
Oncologist
Cancer Research
Medicine
Oncology
A Phase II Study of Docetaxel and Vinorelbine Plus Filgrastim for HER-2 Negative, Stage IV Breast Cancer: SWOG S0102
Breast Cancer Research and Treatment
Cancer Research
Oncology
